Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients.
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2015 |
| Author/s |
author: Christy Ralph Alan Melcher |
| Publication date | November 4, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |